Peter Vozzo | Westwicke Partners, IR |
Jack Khattar | CEO |
Gregory Patrick | CFO |
Kenneth Cacciatore | Cowen and Company |
David Steinberg | Jefferies |
Annabel Samimy | Stifel |
John Boris | SunTrust |
William Tanner | Cantor |
David Amsellem | Piper Jaffray |
David Buck | B. Riley FBR |
Eric Donaldson | Berenberg Capital Markets |
Good morning, ladies and gentlemen, and welcome to Supernus Pharmaceuticals' Fourth Quarter and Full-Year 2018 Financial Results Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke Partners, Investor Relations for Supernus Pharmaceuticals.
You may begin.